VCM
GMED icon

Vigilant Capital Management’s Globus Medical GMED Stock Holding History

Vigilant Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-55
Closed -$4K – 602
2021
Q4 		$4K Sell
55
-114
-67% -$8.28K ﹤0.01% 596
2021
Q3 		$13K Buy
+169
New +$13.6K ﹤0.01% 439
2016
Q3 		– Sell
-182
Closed -$4K – 329
2016
Q2 		$4K Buy
+182
New +$4.37K ﹤0.01% 329

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Vigilant Capital Management's GMED Position: Q1 2022 in Review

Vigilant Capital Management sold out of Globus Medical (GMED) in Q1 2022, closing a stake of 55 shares — an estimated $4K sold.

Vigilant Capital Management first reported a position in GMED in Q2 2016 and held it in 3 quarters. The position peaked at $13K in Q3 2021. 377 funds tracked by Wall St. Rank hold GMED as of Q1 2022.

  • Vigilant Capital Management reported no remaining Globus Medical position as of Q1 2022 after selling out during the quarter.
  • Vigilant Capital Management sold 55 Globus Medical shares in Q1 2022, an estimated $4K.
  • Vigilant Capital Management first reported a position in Globus Medical in Q2 2016 and held it in 3 quarters.
  • Vigilant Capital Management's Globus Medical position peaked at $13K in Q3 2021.
  • 377 funds tracked by Wall St. Rank held Globus Medical as of Q1 2022.

Based on Vigilant Capital Management's 13F filing for Q1 2022, filed 7 Apr 2022.